CN114532426A - Herbal lotus lipid-lowering weight-reducing tea and preparation method thereof - Google Patents
Herbal lotus lipid-lowering weight-reducing tea and preparation method thereof Download PDFInfo
- Publication number
- CN114532426A CN114532426A CN202210230745.1A CN202210230745A CN114532426A CN 114532426 A CN114532426 A CN 114532426A CN 202210230745 A CN202210230745 A CN 202210230745A CN 114532426 A CN114532426 A CN 114532426A
- Authority
- CN
- China
- Prior art keywords
- parts
- tea
- lipid
- reducing
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 240000002853 Nelumbo nucifera Species 0.000 title claims abstract description 34
- 235000006508 Nelumbo nucifera Nutrition 0.000 title claims abstract description 34
- 235000006510 Nelumbo pentapetala Nutrition 0.000 title claims abstract description 34
- 244000269722 Thea sinensis Species 0.000 title claims abstract 10
- 238000002360 preparation method Methods 0.000 title abstract description 11
- 235000013616 tea Nutrition 0.000 claims abstract description 46
- 239000002994 raw material Substances 0.000 claims abstract description 13
- 210000004369 blood Anatomy 0.000 claims abstract description 12
- 239000008280 blood Substances 0.000 claims abstract description 12
- 235000010254 Jasminum officinale Nutrition 0.000 claims abstract description 9
- 240000005385 Jasminum sambac Species 0.000 claims abstract description 9
- 235000019224 Camellia sinensis var Qingmao Nutrition 0.000 claims abstract description 8
- 244000037364 Cinnamomum aromaticum Species 0.000 claims abstract description 8
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims abstract description 8
- 244000183685 Citrus aurantium Species 0.000 claims abstract description 8
- 235000007716 Citrus aurantium Nutrition 0.000 claims abstract description 8
- 235000000228 Citrus myrtifolia Nutrition 0.000 claims abstract description 8
- 235000016646 Citrus taiwanica Nutrition 0.000 claims abstract description 8
- 244000131316 Panax pseudoginseng Species 0.000 claims abstract description 8
- 235000003181 Panax pseudoginseng Nutrition 0.000 claims abstract description 8
- 241000109329 Rosa xanthina Species 0.000 claims abstract description 8
- 235000004789 Rosa xanthina Nutrition 0.000 claims abstract description 8
- 235000020339 pu-erh tea Nutrition 0.000 claims abstract description 8
- 229940026314 red yeast rice Drugs 0.000 claims abstract description 8
- 238000004108 freeze drying Methods 0.000 claims abstract description 4
- 238000004519 manufacturing process Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 20
- 208000010706 fatty liver disease Diseases 0.000 abstract description 17
- 231100000240 steatosis hepatitis Toxicity 0.000 abstract description 17
- 208000004930 Fatty Liver Diseases 0.000 abstract description 16
- 206010019708 Hepatic steatosis Diseases 0.000 abstract description 16
- 230000036541 health Effects 0.000 abstract description 6
- 238000011084 recovery Methods 0.000 abstract description 3
- 230000008092 positive effect Effects 0.000 abstract description 2
- 241001122767 Theaceae Species 0.000 description 37
- 210000004185 liver Anatomy 0.000 description 15
- 239000000463 material Substances 0.000 description 8
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 7
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 239000003205 fragrance Substances 0.000 description 7
- 239000000306 component Substances 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 150000002632 lipids Chemical class 0.000 description 6
- 210000002784 stomach Anatomy 0.000 description 6
- 230000001105 regulatory effect Effects 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 235000009508 confectionery Nutrition 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 235000003143 Panax notoginseng Nutrition 0.000 description 3
- 241000180649 Panax notoginseng Species 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 230000003908 liver function Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 229940126680 traditional chinese medicines Drugs 0.000 description 3
- AKXOIHNFHOEPHN-CQSZACIVSA-N (6ar)-1-methoxy-6-methyl-5,6,6a,7-tetrahydro-4h-dibenzo[de,g]quinoline-2-ol Chemical compound C([C@H]1N(C)CC2)C3=CC=CC=C3C3=C1C2=CC(O)=C3OC AKXOIHNFHOEPHN-CQSZACIVSA-N 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempferol Chemical compound C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 description 2
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 210000005229 liver cell Anatomy 0.000 description 2
- 230000007102 metabolic function Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- XQYZDYMELSJDRZ-UHFFFAOYSA-N papaverine Chemical compound C1=C(OC)C(OC)=CC=C1CC1=NC=CC2=CC(OC)=C(OC)C=C12 XQYZDYMELSJDRZ-UHFFFAOYSA-N 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 229930008281 A03AD01 - Papaverine Natural products 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- UBSCDKPKWHYZNX-UHFFFAOYSA-N Demethoxycapillarisin Natural products C1=CC(O)=CC=C1OC1=CC(=O)C2=C(O)C=C(O)C=C2O1 UBSCDKPKWHYZNX-UHFFFAOYSA-N 0.000 description 1
- 102000002045 Endothelin Human genes 0.000 description 1
- 108050009340 Endothelin Proteins 0.000 description 1
- 229930186217 Glycolipid Natural products 0.000 description 1
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 description 1
- 206010019799 Hepatitis viral Diseases 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- GQODBWLKUWYOFX-UHFFFAOYSA-N Isorhamnetin Natural products C1=C(O)C(C)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 GQODBWLKUWYOFX-UHFFFAOYSA-N 0.000 description 1
- YXVXMURDCBMPRH-UHFFFAOYSA-N Lirinidine Natural products C1C2=CC=CC=C2C2=C(O)C(OC)=CC3=C2C1N(C)CC3 YXVXMURDCBMPRH-UHFFFAOYSA-N 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- ORJVQPIHKOARKV-UHFFFAOYSA-N Nuciferine Natural products C1C2=CC=CC=C2C2=C(OC)C(OC)=CC3=C2C1N(C)CC3 ORJVQPIHKOARKV-UHFFFAOYSA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010033307 Overweight Diseases 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000008358 core component Substances 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- ZUBDGKVDJUIMQQ-UBFCDGJISA-N endothelin-1 Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)NC(=O)[C@H]1NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@@H](CC=2C=CC(O)=CC=2)NC(=O)[C@H](C(C)C)NC(=O)[C@H]2CSSC[C@@H](C(N[C@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N2)=O)NC(=O)[C@@H](CO)NC(=O)[C@H](N)CSSC1)C1=CNC=N1 ZUBDGKVDJUIMQQ-UBFCDGJISA-N 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- IZQSVPBOUDKVDZ-UHFFFAOYSA-N isorhamnetin Chemical compound C1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 IZQSVPBOUDKVDZ-UHFFFAOYSA-N 0.000 description 1
- 235000008800 isorhamnetin Nutrition 0.000 description 1
- 235000008777 kaempferol Nutrition 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229940057059 monascus purpureus Drugs 0.000 description 1
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- ORJVQPIHKOARKV-OAHLLOKOSA-N nuciferine Chemical compound C1C2=CC=CC=C2C2=C(OC)C(OC)=CC3=C2[C@@H]1N(C)CC3 ORJVQPIHKOARKV-OAHLLOKOSA-N 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229960001789 papaverine Drugs 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 230000007863 steatosis Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000003867 tiredness Effects 0.000 description 1
- 208000016255 tiredness Diseases 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 201000001862 viral hepatitis Diseases 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/06—Treating tea before extraction; Preparations produced thereby
- A23F3/14—Tea preparations, e.g. using additives
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
- Non-Alcoholic Beverages (AREA)
Abstract
The invention discloses a herbal lotus tea capable of reducing blood fat and losing weight and a preparation method thereof, and relates to the technical field of health-care drinks. Specifically discloses a lipid-lowering slimming tea which comprises the following components in parts by mass: 3-8 parts of fresh lotus leaves, 1-3 parts of roses, 1-3 parts of citrus aurantium flowers, 1-3 parts of jasmine flowers, 1-3 parts of fried cassia seeds, 1-3 parts of Pu' er tea, 0.5-1 part of red yeast rice and 0.5-1 part of pseudo-ginseng. The preparation method comprises the following steps: freeze-drying fresh lotus leaves, and then crushing the fresh lotus leaves and other raw material components together to obtain the lipid-lowering weight-reducing tea. The health tea has scientific raw material proportion, has excellent effects of reducing fat and losing weight, and has important positive effects on recovery of patients when being used as daily health tea for fatty liver patients.
Description
Technical Field
The invention relates to the technical field of health-care beverages, in particular to a herbal lotus tea capable of reducing fat and losing weight and a preparation method thereof.
Background
Fatty liver (fatty liver) refers to a pathological condition of fat accumulation in liver cells caused by various reasons, and is a common pathological change of liver rather than an independent disease. Fatty liver disease is seriously threatening the health of people, is the second most serious liver disease after viral hepatitis, has continuously increased incidence rate, and the age of the incidence is younger day by day.
Normal human liver tissue contains a small amount of fat, such as triglycerides, phospholipids, glycolipids, and cholesterol, and its weight is about 3% to 5% of the weight of the liver, and if too much fat accumulates in the liver, it exceeds 5% of the weight of the liver or when there is steatosis in more than 50% of the liver cells histologically, it is called fatty liver. The fatty liver is asymptomatic in mild clinical manifestations and violent in severe cases. Fatty liver patients often have the conditions of body obesity and over-standard body weight. Generally, fatty liver belongs to reversible diseases, and the early diagnosis and timely treatment can recover the normal state.
The concept of 'preventing diseases' in the traditional Chinese medicine is gradually deepened into the heart, and the traditional Chinese medicine tea plays an important role as a head-removing soldier in the practice of 'preventing diseases before and after diseases and preventing diseases' in the traditional Chinese medicine. However, the traditional Chinese medicine tea drink is used as a daily health-care drink, the realized liver protection effect is poor, and the slimming effect of fatty liver obese patients is not ideal.
Therefore, the traditional Chinese medicine tea drink with better lipid-lowering and slimming effects is provided, is used for daily health care of fatty liver patients, and has an important positive effect on recovery of the fatty liver patients.
Disclosure of Invention
The invention aims to provide the herbal lotus tea for reducing fat and losing weight and the preparation method thereof, so as to solve the problems in the prior art, so that the traditional Chinese medicine tea has excellent effects of reducing fat and losing weight, and is beneficial to recovery of fatty liver patients.
In order to achieve the purpose, the invention provides the following scheme:
the invention provides a lipid-lowering slimming tea which comprises the following raw material components in parts by mass:
3-8 parts of fresh lotus leaves, 1-3 parts of roses, 1-3 parts of citrus aurantium flowers, 1-3 parts of jasmine flowers, 1-3 parts of fried cassia seeds, 1-3 parts of Pu' er tea, 0.5-1 part of red yeast rice and 0.5-1 part of pseudo-ginseng.
As further optimization of the invention, the lipid-lowering weight-reducing tea comprises the following raw materials in parts by mass:
5 parts of fresh lotus leaves, 2 parts of roses, 2 parts of citrus aurantium, 2 parts of jasmine flowers, 2 parts of fried cassia seeds, 2 parts of Pu' er tea, 1 part of red yeast rice and 1 part of pseudo-ginseng.
The invention also provides a preparation method of the lipid-lowering slimming tea, which comprises the following steps:
freeze-drying the fresh lotus leaves, and then crushing the fresh lotus leaves and other raw material components together to obtain the lipid-lowering weight-losing tea.
The lotus leaf is bitter in taste and neutral in nature. It enters liver, spleen and stomach meridians. Has effects of clearing summerheat, eliminating dampness, promoting hair growth, clearing yang, cooling blood, and stopping bleeding. Record of political essentials: it is thin and inferior when taken with lotus leaves. The lotus leaves are clinically accepted lipid-lowering traditional Chinese medicines and have wide resources, the core components of lipid lowering are quercetin and kaempferol, researches confirm that the isorhamnetin also has a definite lipid-lowering effect, and papaverine, nuciferine, O-nornuciferine and the like synergistically play a lipid-regulating effect.
Semen Cassiae has sweet, bitter, salty and slightly cold property, enters liver and large intestine channels, and has effects of clearing heat, improving eyesight, loosening bowel and relieving constipation. The distribution of cholesterol in vivo is improved by reducing the absorption of exogenous lipid, reducing the synthesis of endogenous lipid and regulating the metabolism of lipid, thereby achieving the effect of reducing blood fat.
The red yeast rice is sweet in taste and warm in nature, enters liver, spleen, stomach and large intestine channels, and has the effects of promoting digestion, harmonizing stomach, promoting blood circulation, relieving pain, invigorating spleen and drying stomach. Modern researches show that the statin components contained in the blood lipid-regulating tea have pharmacological effects of regulating blood lipid, and have the characteristics of safety, low toxicity and high efficiency.
Notoginseng is warm in nature, sweet and slightly bitter in taste, and enters liver and stomach meridians. Has the functions of eliminating swelling, relieving pain, eliminating blood stasis, stopping bleeding, etc. and contains saponin, flavone, notoginseng essence, polysaccharide, etc. Notoginseng radix has effects of dilating and softening blood vessel, reducing blood viscosity, eliminating blood vessel wall calcium deposition, and activating blood vessel endothelin, thereby regulating abnormal blood lipid.
The rose is sweet in taste, slightly bitter in taste and warm in nature, enters liver and spleen channels, soothes liver and relieves depression, activates blood and qi, and is aromatic and resuscitative, and has both edible and medicinal values. Daidaidai flower is slightly cold, fragrant and bitter in taste, and is commonly used for soothing liver, regulating qi, promoting digestion, harmonizing stomach, regulating qi, resolving phlegm, resolving stagnation and the like. The jasmine tea is mainly characterized by containing a large amount of aromatic substances and having health-care effects of calming, warming emotion, resisting oxidation, reducing blood fat, sterilizing, resisting virus, enhancing immunity and the like.
The flower medicinal materials in the invention are all dried flower medicinal materials sold in the market.
The invention discloses the following technical effects:
according to the invention, by utilizing the characteristics of the flower medicinal materials in fragrance emission and the tea fragrance absorption, the flower medicinal materials and the tea are mixed, so that the tea slowly absorbs the flower fragrance, and the prepared scented tea has the tea fragrance and the flower fragrance, and is integrated with the health care functions of the tea fragrance and the flower fragrance.
The invention takes traditional Chinese medicines, flower medicinal materials and tea leaves as raw material components, the formula proportion is scientific, and a preparation method is determined according to the raw material components.
Detailed Description
Reference will now be made in detail to various exemplary embodiments of the invention, the detailed description should not be construed as limiting the invention but as a more detailed description of certain aspects, features and embodiments of the invention.
It is to be understood that the terminology used herein is for the purpose of describing particular embodiments only and is not intended to be limiting of the invention. Further, for numerical ranges in this disclosure, it is understood that each intervening value, between the upper and lower limit of that range, is also specifically disclosed. Every smaller range between any stated value or intervening value in a stated range and any other stated or intervening value in a stated range is encompassed within the invention. The upper and lower limits of these smaller ranges may independently be included or excluded in the range.
Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. Although only preferred methods and materials are described herein, any methods and materials similar or equivalent to those described herein can be used in the practice or testing of the present invention. All documents mentioned in this specification are incorporated by reference herein for the purpose of disclosing and describing the methods and/or materials associated with the documents. In case of conflict with any incorporated document, the present specification will control.
It will be apparent to those skilled in the art that various modifications and variations can be made in the specific embodiments of the present disclosure without departing from the scope or spirit of the disclosure. Other embodiments will be apparent to those skilled in the art from consideration of the specification. The specification and examples are exemplary only.
As used herein, the terms "comprising," "including," "having," "containing," and the like are open-ended terms that mean including, but not limited to.
The "parts" in the present invention are all parts by mass unless otherwise specified.
Example 1
The herbal lotus lipid-lowering weight-reducing tea comprises the following raw materials in parts by mass:
5 parts of fresh lotus leaves, 2 parts of roses, 2 parts of citrus aurantium, 2 parts of jasmine flowers, 2 parts of fried cassia seeds, 2 parts of Pu' er tea, 1 part of red yeast rice and 1 part of pseudo-ginseng.
The preparation method comprises the following steps:
freeze-drying fresh lotus leaves, and then crushing the fresh lotus leaves and other components together according to a ratio to obtain a mixture, namely the herbal lotus tea for reducing fat and losing weight.
Example 2
The herbal lotus lipid-lowering weight-reducing tea comprises the following raw materials in parts by mass:
3 parts of fresh lotus leaves, 2 parts of roses, 3 parts of citrus aurantium, 2 parts of jasmine flowers, 2 parts of fried cassia seeds, 3 parts of Pu' er tea, 1 part of red yeast rice and 0.8 part of pseudo-ginseng.
The preparation method is the same as example 1.
Example 3
The herbal lotus lipid-lowering weight-reducing tea comprises the following raw materials in parts by mass:
8 parts of fresh lotus leaves, 3 parts of roses, 2 parts of citrus aurantium, 3 parts of jasmine flowers, 3 parts of fried cassia seeds, 2 parts of Pu' er tea, 0.7 part of red yeast and 1 part of pseudo-ginseng.
The preparation method is the same as example 1.
When the herbal lotus lipid-lowering weight-reducing tea is drunk, the herbal lotus lipid-lowering weight-reducing tea is only required to be put into a tea bag, then 1 bag of tea (16 g of tea in each bag) is taken and added into 800mL of water, and the herbal lotus lipid-lowering weight-reducing tea is taken after being boiled or soaked in boiled water in a health preserving pot.
Effect verification example:
the evaluation of the curative effect of the invention refers to the evaluation standard of the curative effect of treating fatty liver in the clinical research guiding principles of new traditional Chinese medicines:
clinical cure: clinical symptoms and physical signs disappear, the weight is reduced to be within a normal or overweight range, and liver functions and blood fat are recovered to be normal;
the effect is shown: clinical symptoms and physical signs basically disappear, the weight is reduced by more than 5kg, the liver function is obviously recovered, the Total Cholesterol (TC) in the serum is reduced by more than or equal to 20 percent, and the Triglyceride (TG) is reduced by more than or equal to 40 percent;
the method has the following advantages: clinical symptoms and physical signs are partially disappeared, the weight is reduced by more than 3kg, the liver function is improved, the total serum cholesterol (TC) is reduced by more than or equal to 10% by 20%, and the Triglyceride (TG) is reduced by more than or equal to 20% by 40%.
And (4) invalidation: none of the above mentioned items are significantly improved or aggravated.
The clinical test of the invention totals 141 fatty liver patients (all the fatty liver patients at early stage), wherein 97 male patients and 44 female patients; among the subjects, 102 obese patients, 67 male patients, and 35 female patients were included; the biggest age is 66 years old, the smallest age is 20 years old, and the average age is 33 years old.
The patients take 1 bag of the herbal lotus fat-reducing weight-reducing tea of example 1 of the invention every time, add the herbal lotus fat-reducing weight-reducing tea into 800mL of water, and take the herbal lotus fat-reducing weight-reducing tea by soaking in boiled water 2 times a day. After four months, the conditions of cure, effect, effectiveness and ineffectiveness are counted according to the clinical symptoms and physical sign changes, and the results are shown in table 1.
TABLE 1
| Cure of disease | Show effect | Is effective | Invalidation | |
| Number of people | 108 | 28 | 3 | 2 |
| Ratio (%) | 76.6 | 19.9 | 2.1 | 1.4 |
Typical cases are:
case 1: the weight of a male patient, 29 years old, is increased from 65Kg to 82Kg within half a year before the tea of the invention is drunk, and the male patient is diagnosed as the obese fatty liver by a hospital. After the tea drink is taken for 4 months according to the dosage of 1 bag each time 2 times a day, the weight is reduced to 68Kg, and the liver metabolic function and various indexes are all restored to normal levels; the tracking survey is carried out for 6 months, the weight is stable, other indexes are normal, and no relapse occurs.
Case 2: a female patient is 45 years old and has an obese body and a weight of 78kg, symptoms such as tiredness, hypodynamia, nausea, vomiting, dull pain of liver and the like appear 4 months before taking the tea drink, and the clinical diagnosis is fatty liver. After the tea drink is taken for 3 months according to the dosage of 1 bag each time 2 times a day, the weight is reduced to 69kg, the liver metabolic function and various indexes are recovered to normal level, no relapse is found after tracking and investigating for 6 months, and the weight is stable.
The above-described embodiments are merely illustrative of the preferred embodiments of the present invention, and do not limit the scope of the present invention, and various modifications and improvements of the technical solutions of the present invention can be made by those skilled in the art without departing from the spirit of the present invention, and the technical solutions of the present invention are within the scope of the present invention defined by the claims.
Claims (3)
1. The lipid-lowering weight-reducing tea is characterized by comprising the following raw material components in parts by mass:
3-8 parts of fresh lotus leaves, 1-3 parts of roses, 1-3 parts of citrus aurantium flowers, 1-3 parts of jasmine flowers, 1-3 parts of fried cassia seeds, 1-3 parts of Pu' er tea, 0.5-1 part of red yeast rice and 0.5-1 part of pseudo-ginseng.
2. The lipid-lowering weight-reducing tea of claim 1, which is characterized by comprising the following raw material components in parts by mass:
5 parts of fresh lotus leaves, 2 parts of roses, 2 parts of citrus aurantium, 2 parts of jasmine flowers, 2 parts of fried cassia seeds, 2 parts of Pu' er tea, 1 part of red yeast rice and 1 part of pseudo-ginseng.
3. The process for preparing a tea for reducing blood fat and weight according to any one of claims 1 to 2, comprising the steps of:
freeze-drying the fresh lotus leaves, and then crushing the fresh lotus leaves and other raw material components together to obtain the lipid-lowering weight-losing tea.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210230745.1A CN114532426A (en) | 2022-03-10 | 2022-03-10 | Herbal lotus lipid-lowering weight-reducing tea and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210230745.1A CN114532426A (en) | 2022-03-10 | 2022-03-10 | Herbal lotus lipid-lowering weight-reducing tea and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN114532426A true CN114532426A (en) | 2022-05-27 |
Family
ID=81664113
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202210230745.1A Pending CN114532426A (en) | 2022-03-10 | 2022-03-10 | Herbal lotus lipid-lowering weight-reducing tea and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114532426A (en) |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104171137A (en) * | 2014-08-14 | 2014-12-03 | 刘本德 | Blood pressure-reducing and lipid-lowering tea |
| CN106035860A (en) * | 2016-06-01 | 2016-10-26 | 广西康宝海美三高生态茶有限公司 | Health-preserving bagged tea capable of reducing weight and reducing blood pressure and preparation method of health-preserving bagged tea |
| CN106922896A (en) * | 2015-12-30 | 2017-07-07 | 张培君 | A kind of blood fat reducing tea |
| CN107372979A (en) * | 2017-09-20 | 2017-11-24 | 贵阳健圣堂药材有限公司 | A kind of health protection tea that can help relaxing bowels to lose weight, prevention high fat of blood and fatty liver and preparation method thereof |
| CN109156578A (en) * | 2018-10-26 | 2019-01-08 | 徐宏伟 | A kind of tea for reducing weight and lowering fat |
-
2022
- 2022-03-10 CN CN202210230745.1A patent/CN114532426A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104171137A (en) * | 2014-08-14 | 2014-12-03 | 刘本德 | Blood pressure-reducing and lipid-lowering tea |
| CN106922896A (en) * | 2015-12-30 | 2017-07-07 | 张培君 | A kind of blood fat reducing tea |
| CN106035860A (en) * | 2016-06-01 | 2016-10-26 | 广西康宝海美三高生态茶有限公司 | Health-preserving bagged tea capable of reducing weight and reducing blood pressure and preparation method of health-preserving bagged tea |
| CN107372979A (en) * | 2017-09-20 | 2017-11-24 | 贵阳健圣堂药材有限公司 | A kind of health protection tea that can help relaxing bowels to lose weight, prevention high fat of blood and fatty liver and preparation method thereof |
| CN109156578A (en) * | 2018-10-26 | 2019-01-08 | 徐宏伟 | A kind of tea for reducing weight and lowering fat |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102763884B (en) | Health-care beverage of guava and making method of health-care beverage | |
| CN101317615B (en) | Silver-thorn tea beverage and preparation method thereof | |
| CN104531477A (en) | Peony kidney-nourishing wine and preparation method thereof | |
| CN108185049A (en) | A kind of small green mandarin orange health digestion promoting tea and preparation method thereof | |
| CN105079465A (en) | Composition capable of lowering blood glucose | |
| CN106665775A (en) | Health-care biscuit capable of reducing blood sugar and preparation method thereof | |
| CN111109602A (en) | Medicated functional food suitable for people with diabetes and hyperlipidemia obesity | |
| CN1275551C (en) | Green healthy beverage | |
| CN103719495B (en) | A kind of great burdock achene hypoglycemic health protection tea and preparation method thereof | |
| CN111110792A (en) | Rhizoma polygonati and ginseng tea for controlling sugar, regulating lipid, reducing viscosity, preventing and treating diabetes and complications thereof | |
| CN103749824B (en) | A kind of Herb Gynostemmae Pentaphylli blood sugar lowering blood pressure depressing health tea and preparation method thereof | |
| CN104645107A (en) | Traditional Chinese medicine composition, and preparation method and application thereof | |
| KR101812725B1 (en) | Manufacturing method for pills using medical plants comprising ginseng and pills using medical plants comprising ginseng manufactured by the same | |
| CN104522213A (en) | Tea suitable for three-high crowds and making method of tea suitable for three-high crowds | |
| CN110559389A (en) | traditional Chinese medicine wine for treating hyperuricemia, gout and rheumatism and preparation method thereof | |
| CN105494781A (en) | Giant knotweed rhizome health care tea for reducing blood glucose and lowering blood lipid | |
| CN104783174A (en) | Preparation method of pure natural nutritional, immune and health solid beverage | |
| CN114532426A (en) | Herbal lotus lipid-lowering weight-reducing tea and preparation method thereof | |
| CN108208267A (en) | A kind of lowering blood pressure and blood fat, hypoglycemic and the moulding effect of weight-reducing bag bubble ferment health preserving tea | |
| CN106692760A (en) | Golden flower wine formula for preventing diabetes and preparation method thereof | |
| CN100382832C (en) | Health foods in use for improving symptom in climacteric period of female and fabricating method | |
| CN109674885A (en) | A kind of maintenance prescription for mental worker or frequent alcohol user | |
| CN103340991B (en) | Oral liquid for nursing diabetics and preparation method thereof | |
| CN106804794A (en) | A kind of health protection tea with Weight-reducing and lipid-lowering defaecation effect | |
| CN105311375A (en) | Composition for reducing blood lipid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220527 |